ALX Oncology Holdings Inc. (ALXO)

NASDAQ: ALXO · Real-Time Price · USD

2.060

-0.040 (-1.90%)

At close: Aug 10, 2026, 4:00 PM EDT

2.055

-0.005 (-0.24%)

After-hours: Aug 10, 2026, 7:34 PM EDT

ALX Oncology Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.69	16.37	17.57	22.41	48.82	363.67
Short-Term Investments	115.54	28.42	110.19	160.33	217.39	-
Cash & Short-Term Investments	138.23	44.79	127.76	182.74	266.21	363.67
Cash Growth	74.28%	-64.94%	-30.09%	-31.36%	-26.80%	-16.25%
Other Current Assets	5.23	5.94	6.6	5.92	4.76	3.35
Total Current Assets	143.46	50.73	134.35	188.66	270.97	367.02
Net Property, Plant & Equipment	0.17	1.2	2.91	3.59	3.89	0.9
Long-Term Investments	15.15	3.49	3.52	35.41	16.7	-
Other Long-Term Assets	2.05	3.63	6.99	14.89	14.93	12.27
Total Assets	160.82	59.05	147.78	242.55	306.49	380.18

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.02	4.91	4.65	9.13	9.72	5.39
Accrued Expenses	11.75	14.42	13.42	26.87	18.6	9.9
Current Portion of Long-Term Debt	-	5.22	0.44	-	-	-
Total Current Liabilities	14.78	24.55	18.5	36	28.33	15.3
Long-Term Debt	9.71	4.53	9.47	9.64	9.39	-
Other Long-Term Liabilities	0.15	3.98	6.19	7.2	5.31	1.84
Total Long-Term Liabilities	9.86	8.51	15.66	16.84	14.7	1.84
Total Liabilities	24.63	33.07	34.16	52.84	43.03	17.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.14	0.05	0.05	0	0.04	0.04
Additional Paid-in Capital	894.99	748.72	734.41	675.68	589.74	564.99
Accumulated Other Comprehensive Income	-0.22	0.03	0.28	0.26	-0.85	-
Retained Earnings	-758.72	-722.82	-621.12	-486.27	-325.47	-201.99
Shareholders' Equity	136.19	25.98	113.62	189.71	263.46	363.05
Total Liabilities & Equity	160.82	59.05	147.78	242.55	306.49	380.18

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	9.71	9.75	9.9	9.64	9.39	0
Net Cash (Debt)	128.52	35.04	117.85	173.1	256.82	363.67
Net Cash Growth	85.53%	-70.27%	-31.91%	-32.60%	-29.38%	-16.25%
Net Cash Per Share	1.48	0.65	2.26	4.03	6.31	9.02
Book Value	136.19	25.98	113.62	189.71	263.46	363.05
Book Value Per Share	1.57	0.48	2.18	4.41	6.47	9.01
Tangible Book Value	136.19	25.98	113.62	189.71	263.46	363.05
Tangible Book Value Per Share	1.57	0.48	2.18	4.41	6.47	9.01

SEC Filings: 10-K · 10-Q